Email updates

Keep up to date with the latest news and content from Journal of Hematology & Oncology and BioMed Central.

Open Access Research

Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma

Lu Dai, Yueyu Cao, Yihan Chen, Chris Parsons and Zhiqiang Qin*

  • * Corresponding author: Zhiqiang Qin zqin@lsuhsc.edu

  • † Equal contributors

Journal of Hematology & Oncology 2014, 7:30  doi:10.1186/1756-8722-7-30

PubMed Commons is an experimental system of commenting on PubMed abstracts, introduced in October 2013. Comments are displayed on the abstract page, but during the initial closed pilot, only registered users can read or post comments. Any researcher who is listed as an author of an article indexed by PubMed is entitled to participate in the pilot. If you would like to participate and need an invitation, please email info@biomedcentral.com, giving the PubMed ID of an article on which you are an author. For more information, see the PubMed Commons FAQ.

Negative-feedback loop between Nrf2/KEAP1 axis and xCT-GSH axis in PEL cells

Go Yoshida   (2014-07-25 14:42)  Tokyo Medical and Dental University email

The authors investigated the role of xCT transporter in primary effusion lymphoma (PEL). The treatment of KSHV-infected PEL cells with monosodium glutamate (MSG) and sulfasalazine (SASP) disrupted the synthesis of glutathione (GSH), thereby activating Rac1/p22phox/Nox1/Nox2 axis. Ishii T et al. have recently reviewed that Nrf2 signal pathway contributes to the expression of xCT (Redox Biol. 2014 Apr 18;2:786-794). Thus, it is likely that negative-feedback loop between Nrf2/KEAP1 axis and xCT-GSH axis might exist, resulting in keeping the ROS level in the intermediated level preferential for cellular survival and proliferation but inducing neither cell-cycle arrest nor apoptosis.

Competing interests

No Competing Interests Exist.

top

Post a comment